Names and pronunciation
Retevmo
PDF page 1201
Loading InternPractice…
Drug reference
Retevmo
PDF page 1201
Func. class.: Antineoplastic
PDF page 1201
USES: Metastatic RET fusion–positive non-small cell lung cancer (NSCLC), advanced or metastatic RET-mutant medullary thyroid cancer who require systemic therapy, or advanced or metastatic RET fusion- positive thyroid cancer who require sys- temic therapy and who are radioactive iodine-refractory
PDF page 1201
DOSAGE AND ROUTES Non-small cell lung cancer/thyroid cancer: • Adult: <50 kg: PO 120 mg bid until disease progression or unacceptable tox- icity; ≥50 kg 160 mg bid until disease progression or unacceptable toxicity
PDF page 1201
Available forms: Capsules 40, 80 mg HIGH ALERT
PDF page 1201
• Adult: <50 kg: PO 120 mg bid until disease progression or unacceptable tox- icity; ≥50 kg 160 mg bid until disease progression or unacceptable toxicity
PDF page 1201